Clinical Trial 40209

Garden Grove, CA 92845


Study Summary:

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled,
Parallel-group Study to Assess the Safety and Efficacy of
ASP4345 as Add-on Treatment for Cognitive Impairment
in Subjects with Schizophrenia on Stable Doses
of Antipsychotic Medication


Qualified Participants Must:

• Subject is a male or female subject between 18 to 55 years of age


Qualified Participants May Receive:

Compensation for time and travel 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.